CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 195 filers reported holding CLOVIS ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,017,000 | -28.1% | 22,372 | -16.5% | 0.36% | -60.1% |
| Q1 2018 | $1,414,000 | -0.6% | 26,777 | +28.1% | 0.91% | -21.3% |
| Q4 2017 | $1,422,000 | +2.1% | 20,906 | +23.7% | 1.15% | -19.6% |
| Q3 2017 | $1,393,000 | +8.7% | 16,900 | +23.4% | 1.43% | -10.4% |
| Q2 2017 | $1,282,000 | +86.3% | 13,690 | +26.7% | 1.60% | +35.7% |
| Q1 2017 | $688,000 | -7.9% | 10,805 | -47.9% | 1.18% | +126.5% |
| Q3 2016 | $747,000 | – | 20,730 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |